These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 13632701)
1. Preparation of ceruloplasmin. STEINBUCH M; QUENTIN M Nature; 1959 Jan; 183(4657):323-4. PubMed ID: 13632701 [No Abstract] [Full Text] [Related]
2. Preparation of ceruloplasmin. SANDERS BE; MILLER OP; RICHARD MN Arch Biochem Biophys; 1959 Sep; 84():60-2. PubMed ID: 14441388 [No Abstract] [Full Text] [Related]
3. The preparation of crystalline ceruloplasmin from human plasma. DEUTSCH HF Arch Biochem Biophys; 1960 Aug; 89():225-9. PubMed ID: 13816268 [No Abstract] [Full Text] [Related]
4. The heterogeneity of ceruloplasmin: isolation and characterization of 2 cuproproteins from human serum. RICHTERICH R; TEMPERLI A; AEBI H Biochim Biophys Acta; 1962 Jan; 56():240-51. PubMed ID: 14492064 [No Abstract] [Full Text] [Related]
5. Preparation of an apoprotein from ceruloplasmin by reversible dissociation of copper. MORELL AG; SCHEINBERG IH Science; 1958 Mar; 127(3298):588-90. PubMed ID: 13529022 [No Abstract] [Full Text] [Related]
6. Absence of a relationship between ceruloplasmin and nonspecific hyaluronidase inhibitor. RANTZ LA; RANDALL E AMA Arch Intern Med; 1958 Feb; 101(2):252-3. PubMed ID: 13497322 [No Abstract] [Full Text] [Related]
7. An improved colorimetric enzymatic assay of ceruloplasmin. RAVIN HA J Lab Clin Med; 1961 Jul; 58():161-8. PubMed ID: 13739892 [No Abstract] [Full Text] [Related]
8. Ceruloplasmin reaction in mental disorders. AIVAZIAN GH; GRIFFITH JD AMA Arch Gen Psychiatry; 1960 Jan; 2():7-11. PubMed ID: 13792210 [No Abstract] [Full Text] [Related]
9. Factors influencing serum copper and ceruloplasmin oxidative activity in the rat. MEYER BJ; MEYER AC; HORWITT MK Am J Physiol; 1958 Sep; 194(3):581-4. PubMed ID: 13571430 [No Abstract] [Full Text] [Related]
10. In vitro effect of nonindole compounds on oxidative activity of ceruloplasmin. HANSON KM; AUSTIN DC; APRISON MH J Appl Physiol; 1959 May; 14(3):363-7. PubMed ID: 13654164 [No Abstract] [Full Text] [Related]
11. [Ceruloplasmin in psychiatric research]. SCHOU M Nord Med; 1960 Feb; 63():168-71. PubMed ID: 14443507 [No Abstract] [Full Text] [Related]
12. Comparative study of blood ceruloplasmin in schizophrenia and other disorders. ABOOD LG; GIBBS FA; GIBBS E AMA Arch Neurol Psychiatry; 1957 Jun; 77(6):643-5. PubMed ID: 13423938 [No Abstract] [Full Text] [Related]
13. Preparation of caeruloplasmin from the G2 fraction of human plasma. CURZON G; VALLET L Nature; 1959 Mar; 183(4663):751. PubMed ID: 13644182 [No Abstract] [Full Text] [Related]
14. Continued studies on the effect of ceruloplasmin administration in schizophrenic patients. MARTENS S; VALLBO S; KYHLBERG KO; JONSSON CO J Neuropsychiatr; 1961 Jun; 2():238-45. PubMed ID: 13767284 [No Abstract] [Full Text] [Related]
15. Ceruloplasmin activity and copper levels in the serum of children with schizophrenia. BAKWIN RM J Am Med Womens Assoc; 1961 Jul; 16():522-3. PubMed ID: 13686173 [No Abstract] [Full Text] [Related]
16. Ceruloplasmin, transferrin, and tryptophan in schizophrenia. FROHMAN CE; GOODMAN M; LUBY ED; BECKETT PG; SENF R AMA Arch Neurol Psychiatry; 1958 Jun; 79(6):730-4. PubMed ID: 13532086 [No Abstract] [Full Text] [Related]
17. Studies with ceruloplasmin and a new hallucinogen. OSTFELD AM; ABOOD LG; MARCUS DA AMA Arch Neurol Psychiatry; 1958 Mar; 79(3):317-22. PubMed ID: 13507761 [No Abstract] [Full Text] [Related]